Oncocyte Corp Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Oncocyte Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • Oncocyte Corp Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 13.4M shares, a 61.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 13.4M +5.11M +61.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 13.4M +5.13M +62.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 8.27M -111M -93.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 8.26M +2.33M +39.3% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 8.26M -110M -93% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 8.24M -110M -93.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 119M +27M +29.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 5.93M -86.3M -93.6% Dec 31, 2022 10-K 2024-04-16
Q3 2022 119M +26.5M +28.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 119M +28.3M +31.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 92.2M +3.33M +3.75% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 92.2M +23.1M +33.4% Dec 31, 2021 10-K 2023-04-12
Q3 2021 92.2M +24.9M +37% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 90.3M +23.1M +34.4% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 88.9M +26.4M +42.3% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 69.1M +12.1M +21.2% Dec 31, 2020 10-K 2022-03-11
Q3 2020 67.3M +15.3M +29.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 67.2M +15.2M +29.3% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 62.5M +10.5M +20.2% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 57M +16.4M +40.3% Dec 31, 2019 10-K 2021-03-19
Q3 2019 52M +11.3M +27.8% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 52M +12.6M +31.9% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 52M +14.2M +37.4% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 40.7M +9.21M +29.3% Dec 31, 2018 10-K 2020-03-26
Q3 2018 40.7M +9.25M +29.4% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 39.4M +9.89M +33.5% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 37.8M +8.45M +28.8% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 31.5M +2.72M +9.45% Dec 31, 2017 10-K 2019-04-01
Q3 2017 31.4M +2.74M +9.56% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 29.5M +4.09M +16.1% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 29.4M +3.96M +15.6% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 28.7M +3.35M +13.2% Dec 31, 2016 10-K 2018-04-02
Q3 2016 28.7M Sep 30, 2016 10-Q 2016-11-10
Q2 2016 25.4M Jun 30, 2016 10-Q 2016-08-11
Q1 2016 25.4M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 25.4M Dec 31, 2015 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.